AAAAAA

   
Results: 1-7 |
Results: 7
Tramadol for the treatment of joint pain associated with osteoarthritis: Arandomized, double-blind, placebo-controlled trial
Authors: Fleischmann, RM Caldwell, JR Roth, SH Tesser, JRP Olson, W Kamin, M
Citation: Rm. Fleischmann et al., Tramadol for the treatment of joint pain associated with osteoarthritis: Arandomized, double-blind, placebo-controlled trial, CURR THER R, 62(2), 2001, pp. 113-128
Treatment of rheumatoid arthritis with a DR4/1 peptide
Authors: St Clair, EW Cohen, SB Lee, ML Fleischmann, RM Lee, SH Moreland, LW Olsen, NJ Pratt, PW Yocum, DE Heck, L Winkelhake, J Holcenberg, JS Shulman, MJ
Citation: Ew. St Clair et al., Treatment of rheumatoid arthritis with a DR4/1 peptide, J RHEUMATOL, 27(8), 2000, pp. 1855-1863
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
Authors: Bathon, JM Martin, RW Fleischmann, RM Tesser, JR Schiff, MH Keystone, EC Genovese, MC Wasko, MC Moreland, LW Weaver, AL Markenson, J Finck, BK
Citation: Jm. Bathon et al., A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis, N ENG J MED, 343(22), 2000, pp. 1586-1593
Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain - Placebo-controlled trial and long-term evaluation
Authors: Roth, SH Fleischmann, RM Burch, FX Dietz, F Bockow, B Rapoport, RJ Rutstein, J Lacouture, PG
Citation: Sh. Roth et al., Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain - Placebo-controlled trial and long-term evaluation, ARCH IN MED, 160(6), 2000, pp. 853-860
Early diagnosis and treatment of rheumatoid arthritis for improved outcomes: Focus on etanercept, a new biologic response modifier
Authors: Fleischmann, RM
Citation: Rm. Fleischmann, Early diagnosis and treatment of rheumatoid arthritis for improved outcomes: Focus on etanercept, a new biologic response modifier, CLIN THER, 21(9), 1999, pp. 1429-1442
A trial of etanercept, a recombinant tumor necrosis factor receptor : Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
Authors: Weinblatt, ME Kremer, JM Bankhurst, AD Bulpitt, KJ Fleischmann, RM Fox, RI Jackson, CG Lange, M Burge, DJ
Citation: Me. Weinblatt et al., A trial of etanercept, a recombinant tumor necrosis factor receptor : Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate, N ENG J MED, 340(4), 1999, pp. 253-259
Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial
Authors: Moreland, LW Schiff, MH Baumgartner, SW Tindall, EA Fleischmann, RM Bulpitt, KJ Weaver, AL Keystone, EC Furst, DE Mease, PJ Ruderman, EM Horwitz, DA Arkfeld, DG Garrison, L Burge, DJ Blosch, CM Lange, MLM McDonnell, ND Weinblatt, ME
Citation: Lw. Moreland et al., Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial, ANN INT MED, 130(6), 1999, pp. 478
Risultati: 1-7 |